PA
GILD icon

Pineridge Advisors’s Gilead Sciences GILD Stock Holding History

Pineridge Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$5.77K Hold
52
– – ﹤0.01% 246
2025
Q2 		$5.72K Buy
52
+1
+2% +$106 ﹤0.01% 286
2025
Q1 		$5.74K Hold
51
– – ﹤0.01% 283
2024
Q4 		$4.7K Buy
51
+1
+2% +$90 ﹤0.01% 389
2024
Q3 		$4.23K Sell
50
-35
-41% -$2.67K ﹤0.01% 371
2024
Q2 		$5.85K Hold
85
– – ﹤0.01% 356
2024
Q1 		$6.21K Sell
85
-16
-16% -$1.23K ﹤0.01% 340
2023
Q4 		$8.22K Buy
+101
New +$7.86K ﹤0.01% 414

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pineridge Advisors's GILD Position: Q3 2025 in Review

Pineridge Advisors held its Gilead Sciences (GILD) position steady in Q3 2025 at 52 shares worth $5.77K. The position accounts for ﹤0.01% of the portfolio, ranked #246.

Pineridge Advisors first reported a position in GILD in Q4 2023 and has held it in 8 quarters since. The position peaked at $8.22K in Q4 2023. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Pineridge Advisors held 52 shares of Gilead Sciences worth $5.77K as of Q3 2025.
  • Pineridge Advisors left its Gilead Sciences share count unchanged in Q3 2025.
  • Gilead Sciences made up ﹤0.01% of Pineridge Advisors's portfolio in Q3 2025, its #246 holding.
  • Pineridge Advisors first reported a position in Gilead Sciences in Q4 2023 and has held it in 8 quarters since.
  • Pineridge Advisors's Gilead Sciences position peaked at $8.22K in Q4 2023.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.